Lista de obras -

A clinical and pharmacokinetic study of the combination of etravirine plus raltegravir in HIV patients with expanded intolerance or resistance

artículo científico publicado en 2014

Acute polyradiculopathies in HIV-infected patients ⬇️

artículo científico publicado el 1 de agosto de 1997

Atraumatic Incomplete Sternal Fracture Incidentally Detected in a Human Immunodeficiency Virus Patient at Lung Cancer Screening With Low-Dose Thoracic CT

artículo científico publicado en 2018

Bone mineral density decline according to renal tubular dysfunction and phosphaturia in tenofovir-exposed HIV-infected patients.

artículo científico publicado en 2016

Brief Report: Reduced Cell-Associated HTLV-2 DNA in Antiretroviral Treated HIV-1-HCV-Coinfected Patients Who Either Received Interferon-α/Ribavirin-Based Hepatitis C Therapy or Had Spontaneous HCV RNA Clearance.

artículo científico publicado en 2015

Bryostatin-1 for latent virus reactivation in HIV-infected patients on antiretroviral therapy

artículo científico publicado en 2016

Central nervous system antiretroviral penetration and cognitive functioning in largely pretreated HIV-infected patients

artículo científico publicado en 2014

Changes in Kidney Function and in the Rate of Tubular Dysfunction After Tenofovir Withdrawal or Continuation in HIV-Infected Patients

artículo científico publicado en 2016

Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy

artículo científico publicado en 2012

Clinicoepidemiological characteristics of HIV-infected immigrants attended at a tropical medicine referral unit.

scientific article published on July 2009

Combined effect of sex and age in response to antiretroviral therapy in HIV-infected patients.

artículo científico publicado en 2016

Consensus document on the management of renal disease in HIV-infected patients.

artículo científico publicado en 2014

Delayed liver fibrosis in HTLV-2-infected patients co-infected with HIV-1 and hepatitis C virus with suppressive antiretroviral therapy

artículo científico publicado en 2015

Drug-related and psychopathological symptoms in HIV-positive men who have sex with men who inject drugs during sex (slamsex): Data from the U-SEX GESIDA 9416 Study

scientific article published on 04 December 2019

Effect of 24 weeks of intensification with a CCR5-antagonist on the decay of the HIV-1 latent reservoir.

artículo científico publicado en 2010

Effect of a monthly dose of calcidiol in improving vitamin D deficiency and secondary hyperparathyroidism in HIV-infected patients

artículo científico publicado en 2014

Efficacy and safety of etravirine-containing regimens in a large cohort of HIV/HCV coinfected patients according to liver fibrosis

artículo científico publicado en 2014

Efficacy of dual therapy with lamivudine plus darunavir boosted with ritonavir once daily in HIV-infected patients with nucleoside analogue toxicity

artículo científico publicado en 2014

Efficacy, safety, and lack of interactions with the use of raltegravir in HIV-infected patients undergoing antineoplastic chemotherapy.

artículo científico publicado en 2014

Etravirine-based antiretroviral therapy in HIV/hepatitis C virus coinfected advanced fibrosis patients receiving triple therapy against hepatitis C virus with telaprevir.

artículo científico publicado en 2014

Executive summary of the GeSIDA/National AIDS Plan consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2014).

artículo científico

Executive summary of the consensus document on the management of renal disease in HIV-infected patients.

artículo científico publicado en 2014

Executive summary of the recommendations on the evaluation and management of renal disease in human immunodeficiency virus-infected patients

artículo científico publicado en 2014

Executive summary: Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015.

artículo científico publicado en 2016

Factors associated with the number of drugs in darunavir/cobicistat regimens

artículo científico publicado en 2020

Fibrosis Regression Explains Differences in Outcome in HIV-/HCV-Coinfected Patients with Cirrhosis After Sustained Virological Response.

artículo científico publicado en 2015

Frailty and physical function in older HIV-infected adults.

artículo científico publicado en 2017

Frailty phenotype: a clinical marker of age acceleration in the older HIV-infected population

scientific article published on 24 January 2019

Genotypic tropism testing in proviral DNA to guide maraviroc initiation in aviremic subjects: 48-week analysis of the PROTEST study.

artículo científico publicado en 2014

Genotypic tropism testing of proviral DNA to guide maraviroc initiation in aviraemic subjects: 48-week analysis of results from the PROTEST study.

artículo científico publicado en 2016

HIV-1 reverse transcriptase thumb subdomain polymorphisms associated with virological failure to nucleoside drug combinations

article

High CD8 T cell percentage and HCV replication control are common features in HIV-1 controllers and HTLV-2-co-infected patients with a history of injection drug use

artículo científico publicado en 2019

High levels of CD4⁺ CTLA-4⁺ Treg cells and CCR5 density in HIV-1-infected patients with visceral leishmaniasis.

artículo científico publicado en 2014

Immigrant women living with HIV in Spain: a qualitative approach to encourage medical follow-up

artículo científico publicado en 2014

Immunological characteristics of Spanish IDUs infected with HTLV-2 and HIV-1.

artículo científico publicado en 2011

Impact of a structured HIV testing program in a hospital emergency department and a primary care center

artículo científico publicado en 2019

Improved Outcome of Cytomegalovirus Retinitis in AIDS Patients After Introduction of Protease Inhibitors ⬇️

artículo científico publicado el 1 de octubre de 1998

Incidence and prognosis of immune reconstitution inflammatory syndrome in HIV-associated progressive multifocal leucoencephalopathy.

artículo científico publicado en 2016

Increased HIV infection in patients with stroke in Spain. A 16-year population-based study

scientific article published on 16 December 2019

Increased prevalence of asymptomatic vertebral fractures in HIV-infected patients over 50 years of age

artículo científico publicado en 2018

Increased risk of serious non-AIDS-related events in HIV-infected subjects on antiretroviral therapy associated with a low CD4/CD8 ratio.

artículo científico publicado en 2014

Influence of a methadone maintenance programme on the improved outcome of a cohort on injecting drug users with advanced HIV disease

artículo científico publicado el 1 de septiembre de 1997

Lack of utility of phosphate serum monitoring in HIV-infected patients on a tenofovir-based antiretroviral regimen.

artículo científico publicado en 2010

Lamivudine plus darunavir boosted with ritonavir as simplification dual regimen in HIV-infected patients

artículo científico publicado en 2014

Lipid-Lowering Effect and Efficacy After Switching to Etravirine in HIV-Infected Patients With Intolerance to Suppressive HAART ⬇️

artículo científico publicado el 1 de enero de 2013

Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and 2 nucleosides for maintenance therapy of HIV: 96-week analysis.

artículo científico publicado en 2009

Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and two nucleosides for maintenance therapy of HIV.

artículo científico publicado en 2008

Missing Scheduled Visits in the Outpatient Clinic as a Marker of Short-Term Admissions and Death ⬇️

artículo científico publicado el 1 de septiembre de 2012

Mycobacterial liver abscess in a patient with AIDS ⬇️

artículo científico publicado el 1 de marzo de 1998

Neutropenia during therapy with peginterferon and ribavirin in HIV-infected subjects with chronic hepatitis C and the risk of infections.

artículo científico publicado en 2013

Observational study to evaluate clinical outcomes after first-line efavirenz-or lopinavir-ritonavir-based HAART in treatment-naive patients.

artículo científico publicado en 2009

Out of focus: tailoring the cascade of care to the needs of women living with HIV.

artículo científico publicado en 2017

Outcome of an HIV education program for primary care providers: Screening and late diagnosis rates

scientific article published on 02 July 2019

Outcomes by sex following treatment initiation with darunavir/cobicistat in a large Spanish cohort of the CODAR study (GeSIDA 9316)

artículo científico publicado en 2019

Outcomes by sex following treatment initiation with darunavir/cobicistat in a large Spanish cohort of the CODAR study (GeSIDA 9316)

scientific article published in 2019

Pharmacokinetics of fosamprenavir plus ritonavir in human immunodeficiency virus type 1-infected adult subjects with hepatic impairment.

artículo científico publicado en 2009

Plasma drug levels, genotypic resistance, and virological response to a nelfinavir plus saquinavir-containing regimen ⬇️

artículo científico publicado el 4 de enero de 2002

Pneumococcal vaccination in adult people living with HIV on suppressive antiretroviral therapy: a case-control study

scientific article published on 22 December 2019

Predicting Virological Response to HIV Treatment Over Time: A Tool for Settings With Different Definitions of Virological Response

artículo científico publicado en 2019

Prevalence of Primary Resistance Mutations to Integrase Inhibitors in Treatment-Naïve and -Experienced Patients Infected With B and Non-B HIV-1 Variants ⬇️

artículo científico publicado el 1 de enero de 2013

Prevalence of causes of secondary osteoporosis and contribution to lower bone mineral density in HIV-infected patients.

artículo científico publicado en 2013

Prevalence of insulin resistance and risk of diabetes mellitus in HIV-infected patients receiving current antiretroviral drugs.

artículo científico publicado en 2014

Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015.

artículo científico publicado en 2016

Promoting high standards of care for women living with HIV: position statement from the Women Against Viruses in Europe Working Group.

artículo científico publicado en 2017

Raltegravir pharmacokinetics in HIV/HCV-coinfected patients with advanced liver cirrhosis (Child-Pugh C).

artículo científico publicado en 2013

Regression of liver fibrosis is progressive after sustained virological response to HCV therapy in patients with hepatitis C and HIV coinfection.

artículo científico publicado en 2013

Relevant gender differences in epidemiological profile, exposure to first antiretroviral regimen and survival in the Spanish AIDS Research Network Cohort.

artículo científico publicado en 2013

Reproductive desire in women with HIV infection in Spain, associated factors and motivations: a mixed-method study

artículo científico publicado en 2014

Reproductive history before and after HIV diagnosis: A cross-sectional study in HIV-positive women in Spain.

scientific article published on February 2017

Risk factors for ritonavir intolerance and outcome after change to indinavir

artículo científico publicado el 12 de febrero de 1998

Role of HIV in the desire of procreation and motherhood in women living with HIV in Spain: a qualitative approach

artículo científico publicado en 2018

Safe Coadministration of Raltegravir-Based HAART in HIV-Infected Patients With HCV-Cirrhosis Receiving Triple Therapy With Telaprevir or Boceprevir ⬇️

artículo científico publicado el 1 de noviembre de 2012

Safe co-administration of raltegravir, pegylated-interferon and, ribavirin in HIV individuals with hepatitis C virus-related liver damage.

artículo científico publicado en 2010

Safety and Pharmacokinetics of Lopinavir in HIV/HCV Coinfected Patients with Advanced Liver Disease ⬇️

artículo científico publicado el 1 de septiembre de 2011

Short communication: lamivudine plus a boosted-protease inhibitor as simplification strategy in HIV-infected patients: proof of concept.

artículo científico publicado en 2012

Social isolation in HIV-infected patients according to subjective patient assessment and DEXA-confirmed severity of lipodystrophy.

artículo científico publicado en 2013

Surveillance of transmitted drug resistance to integrase inhibitors in Spain: implications for clinical practice

artículo científico publicado en 2019

Switching to Raltegravir in Virologically Suppressed in HIV-1-Infected Patients: A Retrospective, Multicenter, Descriptive Study

article

Switching to abacavir versus use of a nucleoside-sparing dual regimen for HIV-infected patients with tenofovir-associated renal toxicity

artículo científico publicado en 2018

The F4/AS01B HIV-1 Vaccine Candidate Is Safe and Immunogenic, But Does Not Show Viral Efficacy in Antiretroviral Therapy-Naive, HIV-1-Infected Adults: A Randomized Controlled Trial.

artículo científico publicado en 2016

The effect of intensification with raltegravir on the HIV-1 reservoir of latently infected memory CD4 T cells in suppressed patients.

artículo científico publicado en 2012

The influence of patient beliefs and treatment satisfaction on the discontinuation of current first-line antiretroviral regimens

artículo científico publicado en 2015

The role of SEAD project intervention in viral suppression of HIV/AIDS patients with follow-up and adherence barriers.

artículo científico publicado en 2012

The use of atazanavir in HIV-infected patients with liver cirrhosis: lack of hepatotoxicity and no significant changes in bilirubin values or model for end-stage liver disease score ⬇️

artículo científico publicado el 24 de abril de 2011

Transmission of HIV drug resistance and non-B subtype distribution in the Spanish cohort of antiretroviral treatment naïve HIV-infected individuals (CoRIS).

artículo científico publicado en 2011

Tuberculous prostatic abscess in acquired immunodeficiency syndrome

artículo científico publicado el 1 de mayo de 1997

Use of cohort data to estimate national prevalence of transmitted drug resistance to antiretroviral drugs in Spain (2007-2012).

artículo científico publicado en 2014

Virological response to short-course maraviroc monotherapy does not predict viral tropism in HIV-1-infected treatment-naive patients.

artículo científico publicado en 2014

Visceral leishmaniasis as an independent cause of high immune activation, T-cell senescence, and lack of immune recovery in virologically suppressed HIV-1-coinfected patients.

artículo científico publicado en 2015

Weight gain in people living with HIV switched to dual therapy: changes in body fat mass

artículo científico publicado en 2020

Lista de obras de

A clinical and pharmacokinetic study of the combination of etravirine plus raltegravir in HIV patients with expanded intolerance or resistance

Acute polyradiculopathies in HIV-infected patients ⬇️

Atraumatic Incomplete Sternal Fracture Incidentally Detected in a Human Immunodeficiency Virus Patient at Lung Cancer Screening With Low-Dose Thoracic CT

Bone mineral density decline according to renal tubular dysfunction and phosphaturia in tenofovir-exposed HIV-infected patients.

Brief Report: Reduced Cell-Associated HTLV-2 DNA in Antiretroviral Treated HIV-1-HCV-Coinfected Patients Who Either Received Interferon-α/Ribavirin-Based Hepatitis C Therapy or Had Spontaneous HCV RNA Clearance.

Bryostatin-1 for latent virus reactivation in HIV-infected patients on antiretroviral therapy

Central nervous system antiretroviral penetration and cognitive functioning in largely pretreated HIV-infected patients

Changes in Kidney Function and in the Rate of Tubular Dysfunction After Tenofovir Withdrawal or Continuation in HIV-Infected Patients

Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy

Clinicoepidemiological characteristics of HIV-infected immigrants attended at a tropical medicine referral unit.

Combined effect of sex and age in response to antiretroviral therapy in HIV-infected patients.

Consensus document on the management of renal disease in HIV-infected patients.

Delayed liver fibrosis in HTLV-2-infected patients co-infected with HIV-1 and hepatitis C virus with suppressive antiretroviral therapy

Drug-related and psychopathological symptoms in HIV-positive men who have sex with men who inject drugs during sex (slamsex): Data from the U-SEX GESIDA 9416 Study

Effect of 24 weeks of intensification with a CCR5-antagonist on the decay of the HIV-1 latent reservoir.

Effect of a monthly dose of calcidiol in improving vitamin D deficiency and secondary hyperparathyroidism in HIV-infected patients

Efficacy and safety of etravirine-containing regimens in a large cohort of HIV/HCV coinfected patients according to liver fibrosis

Efficacy of dual therapy with lamivudine plus darunavir boosted with ritonavir once daily in HIV-infected patients with nucleoside analogue toxicity

Efficacy, safety, and lack of interactions with the use of raltegravir in HIV-infected patients undergoing antineoplastic chemotherapy.

Etravirine-based antiretroviral therapy in HIV/hepatitis C virus coinfected advanced fibrosis patients receiving triple therapy against hepatitis C virus with telaprevir.

Executive summary of the GeSIDA/National AIDS Plan consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2014).

Executive summary of the consensus document on the management of renal disease in HIV-infected patients.

Executive summary of the recommendations on the evaluation and management of renal disease in human immunodeficiency virus-infected patients

Executive summary: Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015.

Factors associated with the number of drugs in darunavir/cobicistat regimens

Fibrosis Regression Explains Differences in Outcome in HIV-/HCV-Coinfected Patients with Cirrhosis After Sustained Virological Response.

Frailty and physical function in older HIV-infected adults.

Frailty phenotype: a clinical marker of age acceleration in the older HIV-infected population

Genotypic tropism testing in proviral DNA to guide maraviroc initiation in aviremic subjects: 48-week analysis of the PROTEST study.

Genotypic tropism testing of proviral DNA to guide maraviroc initiation in aviraemic subjects: 48-week analysis of results from the PROTEST study.

HIV-1 reverse transcriptase thumb subdomain polymorphisms associated with virological failure to nucleoside drug combinations

High CD8 T cell percentage and HCV replication control are common features in HIV-1 controllers and HTLV-2-co-infected patients with a history of injection drug use

High levels of CD4⁺ CTLA-4⁺ Treg cells and CCR5 density in HIV-1-infected patients with visceral leishmaniasis.

Immigrant women living with HIV in Spain: a qualitative approach to encourage medical follow-up

Immunological characteristics of Spanish IDUs infected with HTLV-2 and HIV-1.

Impact of a structured HIV testing program in a hospital emergency department and a primary care center

Improved Outcome of Cytomegalovirus Retinitis in AIDS Patients After Introduction of Protease Inhibitors ⬇️

Incidence and prognosis of immune reconstitution inflammatory syndrome in HIV-associated progressive multifocal leucoencephalopathy.

Increased HIV infection in patients with stroke in Spain. A 16-year population-based study

Increased prevalence of asymptomatic vertebral fractures in HIV-infected patients over 50 years of age

Increased risk of serious non-AIDS-related events in HIV-infected subjects on antiretroviral therapy associated with a low CD4/CD8 ratio.

Influence of a methadone maintenance programme on the improved outcome of a cohort on injecting drug users with advanced HIV disease

Lack of utility of phosphate serum monitoring in HIV-infected patients on a tenofovir-based antiretroviral regimen.

Lamivudine plus darunavir boosted with ritonavir as simplification dual regimen in HIV-infected patients

Lipid-Lowering Effect and Efficacy After Switching to Etravirine in HIV-Infected Patients With Intolerance to Suppressive HAART ⬇️

Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and 2 nucleosides for maintenance therapy of HIV: 96-week analysis.

Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and two nucleosides for maintenance therapy of HIV.

Missing Scheduled Visits in the Outpatient Clinic as a Marker of Short-Term Admissions and Death ⬇️

Mycobacterial liver abscess in a patient with AIDS ⬇️

Neutropenia during therapy with peginterferon and ribavirin in HIV-infected subjects with chronic hepatitis C and the risk of infections.

Observational study to evaluate clinical outcomes after first-line efavirenz-or lopinavir-ritonavir-based HAART in treatment-naive patients.

Out of focus: tailoring the cascade of care to the needs of women living with HIV.

Outcome of an HIV education program for primary care providers: Screening and late diagnosis rates

Outcomes by sex following treatment initiation with darunavir/cobicistat in a large Spanish cohort of the CODAR study (GeSIDA 9316)

Outcomes by sex following treatment initiation with darunavir/cobicistat in a large Spanish cohort of the CODAR study (GeSIDA 9316)

Pharmacokinetics of fosamprenavir plus ritonavir in human immunodeficiency virus type 1-infected adult subjects with hepatic impairment.

Plasma drug levels, genotypic resistance, and virological response to a nelfinavir plus saquinavir-containing regimen ⬇️

Pneumococcal vaccination in adult people living with HIV on suppressive antiretroviral therapy: a case-control study

Predicting Virological Response to HIV Treatment Over Time: A Tool for Settings With Different Definitions of Virological Response

Prevalence of Primary Resistance Mutations to Integrase Inhibitors in Treatment-Naïve and -Experienced Patients Infected With B and Non-B HIV-1 Variants ⬇️

Prevalence of causes of secondary osteoporosis and contribution to lower bone mineral density in HIV-infected patients.

Prevalence of insulin resistance and risk of diabetes mellitus in HIV-infected patients receiving current antiretroviral drugs.

Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015.

Promoting high standards of care for women living with HIV: position statement from the Women Against Viruses in Europe Working Group.

Raltegravir pharmacokinetics in HIV/HCV-coinfected patients with advanced liver cirrhosis (Child-Pugh C).

Regression of liver fibrosis is progressive after sustained virological response to HCV therapy in patients with hepatitis C and HIV coinfection.

Relevant gender differences in epidemiological profile, exposure to first antiretroviral regimen and survival in the Spanish AIDS Research Network Cohort.

Reproductive desire in women with HIV infection in Spain, associated factors and motivations: a mixed-method study

Reproductive history before and after HIV diagnosis: A cross-sectional study in HIV-positive women in Spain.

Risk factors for ritonavir intolerance and outcome after change to indinavir

Role of HIV in the desire of procreation and motherhood in women living with HIV in Spain: a qualitative approach

Safe Coadministration of Raltegravir-Based HAART in HIV-Infected Patients With HCV-Cirrhosis Receiving Triple Therapy With Telaprevir or Boceprevir ⬇️

Safe co-administration of raltegravir, pegylated-interferon and, ribavirin in HIV individuals with hepatitis C virus-related liver damage.

Safety and Pharmacokinetics of Lopinavir in HIV/HCV Coinfected Patients with Advanced Liver Disease ⬇️

Short communication: lamivudine plus a boosted-protease inhibitor as simplification strategy in HIV-infected patients: proof of concept.

Social isolation in HIV-infected patients according to subjective patient assessment and DEXA-confirmed severity of lipodystrophy.

Surveillance of transmitted drug resistance to integrase inhibitors in Spain: implications for clinical practice

Switching to Raltegravir in Virologically Suppressed in HIV-1-Infected Patients: A Retrospective, Multicenter, Descriptive Study

Switching to abacavir versus use of a nucleoside-sparing dual regimen for HIV-infected patients with tenofovir-associated renal toxicity